Please use this identifier to cite or link to this item:
https://hdl.handle.net/10923/23949
| Type: | Article |
| Title: | A phase 2 randomized clinical trial of abiraterone plus ADT, apalutamide, or abiraterone and apalutamide in patients with advanced prostate cancer with non-castrate testosterone levels (LACOG 0415) |
| Author(s): | MALUF, FERNANDO C.
SCHUTZ, FABIO A.
CRONEMBERGER, EDUARDO H.
LUZ, MURILO DE A.
MARTINS, SUELEN P.S.
MUNIZ, DAVID Q.B.
BASTOS, DIOGO A.
CÁRCANO, FLAVIO M.
SMALETZ, OREN
SOARES, ANDREY
PEIXOTO, FÁBIO A.
GOMES, ANDREA J.
CRUZ, FELIPE M.
FRANKE, FABIO A.
HERCHENHORN, DANIEL
DOS SANTOS, TELMA M.
FABRICIO, VANESSA DE C.
GIDEKEL, ROSEMARIE
WERUTSKY, GUSTAVO
DE JESUS, RAFAELA G.
SOUZA, VINICIUS C.
André Poisl Fay |
| In: | EUROPEAN JOURNAL OF CANCER |
| Issue Date: | 2021 |
| Volume: | 158 |
| First page: | 63 |
| Last page: | 71 |
| URI: | https://hdl.handle.net/10923/23949 |
| DOI: | DOI:10.1016/j.ejca.2021.08.032 |
| ISSN: | 0959-8049 |
| Appears in Collections: | Artigo de Periódico
|
All Items in PUCRS Repository are protected by copyright, with all rights reserved, and are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. Read more.
